Jeffrey R Andolina

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc Shwachman-Diamond syndrome: diarrhea, no longer required?
    Jeffrey R Andolina
    Department of Pediatrics, Golisano Children s Hospital, University of Rochester Medical Center, Rochester, NY, USA
    J Pediatr Hematol Oncol 35:486-9. 2013
  2. pmc How I treat childhood CML
    Jeffrey R Andolina
    Department of Pediatrics, Golisano Children s Hospital, University of Rochester Medical Center, Rochester, NY, USA
    Blood 119:1821-30. 2012
  3. doi request reprint Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: improved outcomes for de novo disease
    Jeffrey R Andolina
    Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA
    Pediatr Transplant 15:334-43. 2011

Detail Information

Publications3

  1. pmc Shwachman-Diamond syndrome: diarrhea, no longer required?
    Jeffrey R Andolina
    Department of Pediatrics, Golisano Children s Hospital, University of Rochester Medical Center, Rochester, NY, USA
    J Pediatr Hematol Oncol 35:486-9. 2013
    ..258+2 T>C in the Shwachman-Bodian-Diamond syndrome gene. Incomplete phenotypes may be more common than previously recognized in bone marrow failure syndromes; gastrointestinal symptoms should not be considered a prerequisite for SDS. ..
  2. pmc How I treat childhood CML
    Jeffrey R Andolina
    Department of Pediatrics, Golisano Children s Hospital, University of Rochester Medical Center, Rochester, NY, USA
    Blood 119:1821-30. 2012
    ..Although we recommend adopting adult clinical experience to guide therapeutic decision making, the issues of infant CML, drug formulation, pharmacokinetics, and adolescent compliance merit clinical investigation...
  3. doi request reprint Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: improved outcomes for de novo disease
    Jeffrey R Andolina
    Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA
    Pediatr Transplant 15:334-43. 2011
    ..Larger series are needed to confirm prognostic factors so that higher-risk patients can be targeted with novel approaches...